FRANCISCO
ALÉN FARIÑAS
Profesor contratado doctor
Publicaciones (50) Publicaciones de FRANCISCO ALÉN FARIÑAS
2023
-
Awake and Sleep Bruxism Prevalence and Their Associated Psychological Factors in First-Year University Students: A Pre-Mid-Post COVID-19 Pandemic Comparison
International Journal of Environmental Research and Public Health, Vol. 20, Núm. 3, pp. 2452
2022
-
Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"
Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461
-
Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral β1 receptors
Neuropsychopharmacology, Vol. 47, Núm. 8, pp. 1449-1460
2021
-
Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking
Addiction Biology, Vol. 26, Núm. 3
-
Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 108
-
Sex-specific behavioral and neurogenic responses to cocaine in mice lacking and blocking dopamine D1 or dopamine D2 receptors
Journal of Comparative Neurology, Vol. 529, Núm. 8, pp. 1724-1742
-
Sudden cessation of fluoxetine before alcohol drinking reinstatement alters microglial morphology and TLR4/inflammatory neuroadaptation in the rat brain
Brain Structure and Function, Vol. 226, Núm. 7, pp. 2243-2264
2020
-
Adaptive Stress Coping in Awake Bruxism
Frontiers in Neurology, Vol. 11
-
Antianhedonic and antidepressant effects of Affron® a standardized saffron (Crocus Sativus L.) extract
Molecules, Vol. 25, Núm. 14
-
Cessation of fluoxetine treatment increases alcohol seeking during relapse and dysregulates endocannabinoid and glutamatergic signaling in the central amygdala
Addiction Biology, Vol. 25, Núm. 5
2019
-
Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats
Addiction Biology, Vol. 24, Núm. 5, pp. 1019-1033
-
Bupropion, a possible antidepressant without negative effects on alcohol relapse
European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 756-765
-
Oleoylethanolamide modulates BDNF-ERK signaling and neurogenesis in the hippocampi of rats exposed to δ9-THC and ethanol binge drinking during adolescence
Frontiers in Molecular Neuroscience, Vol. 12
-
Oleoylethanolamide, neuroinflammation, and alcohol abuse
Frontiers in Molecular Neuroscience, Vol. 11
-
Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants
Neuropharmacology, Vol. 149, pp. 212-220
-
Rethinking the Use of Antidepressants to Treat Alcohol Use Disorders and Depression Comorbidity: The Role of Neurogenesis
Antidepressants - Preclinical, Clinical and Translational Aspects
-
Role of the galanin N-terminal fragment (1-15) in anhedonia: Involvement of the dopaminergic mesolimbic system
Journal of Psychopharmacology, Vol. 33, Núm. 6, pp. 737-747
-
Sex-Dimorphic Behavioral Alterations and Altered Neurogenesis in U12 Intron Splicing-Defective Zrsr1 Mutant Mice
International Journal of Molecular Sciences, Vol. 20, Núm. 14
2018
-
Impaired Spermatogenesis, Muscle, and Erythrocyte Function in U12 Intron Splicing-Defective Zrsr1 Mutant Mice
Cell Reports, Vol. 23, Núm. 1, pp. 143-155
-
Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women
Addiction Biology, Vol. 23, Núm. 6, pp. 1242-1250